The effect of endogenous angiotensin II on alveolar fluid clearance in rats with acute lung injury

Canadian Respiratory Journal

Volumn 19, Issue 5, 2012, Pages 311-318

  Deng, Jia ^a   Wang, Dao Xin ^a   Deng, Wang ^a   Li, Chang Yi ^a   Tong, Jin ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Acute lung injury; Alveolar fluid clearance; Angiotensin II; Epithelial sodium channel

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; EPITHELIAL SODIUM CHANNEL; LIPOPOLYSACCHARIDE; MESSENGER RNA; SODIUM CHLORIDE; UNCLASSIFIED DRUG; ZD 7155;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL ANIMAL; LUNG ALVEOLUS; LUNG EDEMA; LUNG FLUID; LUNG PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

EID: 84871003390     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2012/951025     Document Type: Article

References (36)

1. Worthen GS, Haslett C, Rees AJ, Gumbay RS, Henson JE, Henson PM. Neutrophil-mediated pulmonary vascular injury. Synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung. Am Rev Respir Dis 1987;136:19-28. (Pubitemid 18026428)
2. Wang F, Xia ZF, Chen XL, Jia YT, Wang YJ, Ma B. Angiotensin II type-1 receptor antagonist attenuates LPS-induced acute lung injury. Cytokine 2009;48:246-53.
3. Hassoun PM, Yu FS, Cote CG, et al. Upregulation of xanthine oxidase by lipopolysaccharide, interleukin-1, and hypoxia. Role in acute lung injury. Am J Respir Crit Care Med 1998;158:299-305. (Pubitemid 28337194)
4. Sato K, Suga M, Akaike T, et al. Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice. Am J Respir Crit Care Med 1998;157:853-7.
5. Kelleher ZT, Potts EN, Brahmajothi MV, et al. NOS2 regulation of LPS-induced airway inflammation via S-nitrosylation of NF-{kappa}B p65. Am J Physiol Lung Cell Mol Physiol 2011;301:327-33.
6. Lucas R, Verin AD, Black SM, Catravas JD. Regulators of endothelial and epithelial barrier integrity and function in acute lung injury. Biochem Pharmacol 2009;77:1763-72.
7. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;163:1376-83. (Pubitemid 32506602)
8. Beutler KT, Masilamani S, Turban S, et al. Long-term regulation of ENaC expression in kidney by angiotensin II. Hypertension 2003;41:1143-50. (Pubitemid 36548617)
9. Imai Y, Kuba K, Penninger JM. The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice. Exp Physiol 2008;93:543-8. (Pubitemid 351595063)
10. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol 2003;35:881-900. (Pubitemid 36379329)
11. Abdi R, Dong VM, Lee CJ, Ntoso KA. Angiotensin II receptor blocker-associated angioedema: On the heels of ACE inhibitor angioedema. Pharmacotherapy 2002;22:1173-5. (Pubitemid 34969071)
12. Kiely DG, Cargill RI, Wheeldon NM, Coutie WJ, Lipworth BJ. Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale. Cardiovasc Res 1997;33:201-8. (Pubitemid 27019116)
13. Xu ZH, Shimakura K, Yamamoto T, Wang LM, Mineshita S. Pulmonary edema induced by angiotensin I in rats. Jpn J Pharmacol 1998;76:51-6. (Pubitemid 28068639)
14. Yamamoto T, Wang L, Shimakura K, Sanaka M, Koike Y, Mineshita S. Angiotensin II-induced pulmonary edema in a rabbit model. Jpn J Pharmacol 1997;73:33-40. (Pubitemid 27078008)
15. Wösten-van Asperen RM, Lutter R, Specht PA, et al. Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist. J Pathol 2011;225(4):618-627.
16. Sakuma T, Zhao Y, Sugita M, et al. Malnutrition impairs alveolar fluid clearance in rat lungs. Am J Physiol Lung Cell Mol Physiol 2004;286:1268-74.
17. Hager H, Kwon TH, Vinnikova AK, et al. Immunocytochemical and immunoelectron microscopic localization of alpha-, beta-, and gamma-ENaC in rat kidney. Am J Physiol Renal Physiol 2001;280:1093-106.
18. Deng J, Wang DX, Deng W, Li CY, Tong J, Ma H. Regulation of alveolar fluid clearance and ENaC expression in lung by exogenous angiotensin II. Respir Physiol Neurobiol 2011 (Epub ahead of print).
19. Tanemoto M, Uchida S. Angiotensin II-induced phosphorylation of the sodium chloride cotransporter. Kidney Int 2011;79:1381-2.
20. Sangalli F, Carrara F, Gaspari F, et al. Effect of ACE inhibition on glomerular permselectivity and tubular albumin concentration in the renal ablation model. Am J Physiol Renal Physiol 2011;300:1291-300.
21. Li C, Wang W, Rivard CJ, Lanaspa MA, Summer S, Schrier RW. Molecular mechanisms of angiotensin II stimulation on aquaporin-2 expression and trafficking. Am J Physiol Renal Physiol 2011;300:1255-61.
22. 1 receptor agonism. Am J Physiol Gastrointest Liver Physiol 2008;295:348-56.
23. Jernigan NL, Speed J, LaMarca B, Granger JP, Drummond HA. Angiotensin II regulation of renal vascular ENaC proteins. Am J Hypertens 2009;22:593-7.
24. Benos DJ, Saccomani G, Sariban-Sohraby S. The epithelial sodium channel. Subunit number and location of the amiloride binding site. J Biol Chem 1987;262:10613-8. (Pubitemid 17127044)
25. Wang Q, Horisberger JD, Maillard M, Brunner HR, Rossier BC, Burnier M. Salt-and angiotensin II-dependent variations in amiloride-sensitive rectal potential difference in mice. Expression and activity of NKCC2, NCC, and ENaC in the obese Zucker rat. Am J Physiol Clin Exp Pharmacol Physiol 2000;27:60-6. (Pubitemid 30104092)
26. Madala Halagappa VK, Tiwari S, Riazi S, Hu X, Ecelbarger CM. Chronic candesartan alters expression and activity of NKCC2, NCC, and ENaC in the obese Zucker rat. Am J Physiol Renal Physiol 2008;294:1222-31.
27. Lütken SC, Kim SW, Jonassen T, et al. Changes of renal AQP2, ENaC, and NHE3 in experimentally induced heart failure: Response to angiotensin II AT1 receptor blockade. Am J Physiol Renal Physiol 2009;297:1678-88.
28. Johnson MD, Bao HF, Helms MN, et al. Functional ion channels in pulmonary alveolar type I cells support a role for type I cells in lung ion transport. Proc Natl Acad Sci USA 2006;103:4964-9.
29. Jain L, Chen XJ, Ramosevac S, Brown LA, Eaton DC. Expression of highly selective sodium channels in alveolar type II cells is determined by culture conditions. Am J Physiol Lung Cell Mol Physiol 2001;280:646-58.
30. Randrianarison N, Clerici C, Ferreira C, et al. Low expression of the beta-ENaC subunit impairs lung fluid clearance in the mouse. Am J Physiol Lung Cell Mol Physiol 2008;294:409-16.
31. Nakada TA, Russell JA, Boyd JH, et al. Association of angiotensin II type 1 receptor-associated protein gene polymorphism with increased mortality in septic shock. Crit Care Med 2011;39:1641-8.
32. Medzhitov R, Horng T. Transcriptional control of the inflammatory response. Nat Rev Immunol 2009;9:692-703.
33. Rateri DL, Moorleghen JJ, Balakrishnan A, et al. Endothelial cell-specific deficiency of Ang II type 1a receptors attenuates Ang II-induced ascending aortic aneurysms in LDL receptor -/- mice. Circ Res 2011;108:574-81.
34. Yamagata T, Yamagata Y, Nishimoto T, et al. The regulation of amiloride-sensitive epithelial sodium channels by tumor necrosis factor-alpha in injured lungs and alveolar type II cells. Respir Physiol Neurobiol 2009;166:16-23.
35. Roux J, Kawakatsu H, Gartland B, et al. Interleukin-1beta decreases expression of the epithelial sodium channel alpha-subunit in alveolar epithelial cells via a p38 MAPK-dependent signaling pathway. J Biol Chem 2005;280:18579-89. (Pubitemid 41379556)
36. Boncoeur E, Tardif V, Tessier MC, et al. Modulation of epithelial sodium channel activity by lipopolysaccharide in alveolar type II cells: involvement of purinergic signaling. Am J Physiol Lung Cell Mol Physiol 2010;298:417-26.